This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

This study has been terminated.
Information provided by:
University Hospital, Angers Identifier:
First received: August 31, 2005
Last updated: NA
Last verified: August 2005
History: No changes posted
Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.

Condition Intervention Phase
Hydration Loss of Consciousness Neurocardiogenic Syncope Procedure: Hydration Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Benefit of Controlled Rehydration in Unexplained Syncope

Resource links provided by NLM:

Further study details as provided by University Hospital, Angers:


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Syncopal and/or near syncopal episodes at least twice within the prior 3 months

Exclusion Criteria:

  • Neurological disease
  • Structural heart disease
  • Metabolic and psychiatric illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00143754

Sponsors and Collaborators
University Hospital, Angers
Principal Investigator: Georges PN Leftheriotis, MD-PhD HUAngers
  More Information Identifier: NCT00143754     History of Changes
Other Study ID Numbers: CP00-02
Centre Evian pour l'Eau
Study First Received: August 31, 2005
Last Updated: August 31, 2005

Additional relevant MeSH terms:
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms processed this record on September 21, 2017